amphetamine has been researched along with Abnormalities, Congenital, Nervous System in 2 studies
Amphetamine: A powerful central nervous system stimulant and sympathomimetic. Amphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulation of release of monamines, and inhibiting monoamine oxidase. Amphetamine is also a drug of abuse and a psychotomimetic. The l- and the d,l-forms are included here. The l-form has less central nervous system activity but stronger cardiovascular effects. The d-form is DEXTROAMPHETAMINE.
1-phenylpropan-2-amine : A primary amine that is isopropylamine in which a hydrogen attached to one of the methyl groups has been replaced by a phenyl group.
amphetamine : A racemate comprising equimolar amounts of (R)-amphetamine (also known as levamphetamine or levoamphetamine) and (S)-amphetamine (also known as dexamfetamine or dextroamphetamine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shin, DM | 1 |
| Korada, S | 1 |
| Raballo, R | 1 |
| Shashikant, CS | 1 |
| Simeone, A | 1 |
| Taylor, JR | 1 |
| Vaccarino, F | 1 |
| Swerdlow, NR | 1 |
| Halim, N | 1 |
| Hanlon, FM | 1 |
| Platten, A | 1 |
| Auerbach, PP | 1 |
2 other studies available for amphetamine and Abnormalities, Congenital, Nervous System
| Article | Year |
|---|---|
Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice.
Topics: Adrenergic alpha-Agonists; Amphetamine; Animals; Cell Differentiation; Cell Division; Frontal Lobe; | 2004 |
Lesion size and amphetamine hyperlocomotion after neonatal ventral hippocampal lesions: more is less.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Animals, Newborn; Behavior, Animal; Denervation; | 2001 |